Technology could improve early diagnosis, ease pressure on health systems, and help address rising antibiotic resistance, a global threat.

Extracorporeal membrane oxygenation (ECMO) technology has relative contraindications in haemorrhagic disease but remains an effective therapeutic option for the treatment of pulmonary haemorrhage ...

Alveolar macrophages are immune cells that live in the tiny air sacs of the lungs. Under normal conditions, these cells act ...

Lung development begins during embryogenesis and continues after birth. It includes branching of airways, formation of ...

Particularly alarming for service members are studies showing that microplastics were present in 99% of post-mortem lung ...

Alveolar macrophages are immune cells that live in the tiny air sacs of the lungs. Under normal conditions, these cells act ...

Alveolar macrophages are immune cells that live in the tiny air sacs of the lungs. Under normal conditions, these cells act ...

Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysemaAdditional orphan designation ...

A cough that lasts for more than three weeks can be an indicator of a more serious situation, such as lung cancer. Lung ...

Sanofi (EURONEXT: SAN) announced Wednesday that its investigational therapy, efdoralprin alfa, has received orphan drug ...